Investment
Features
FeesSafety
Academy
More
Pluang+

Compare AbCellera Biologics Inc (ABCL) vs Enbridge Inc (ENB) Price & Performance

AbCellera Biologics IncTrade
Enbridge IncTrade

Price performance (Past 24H)

Key statistics

AbCellera Biologics Inc vs Enbridge Inc — how do they compare? AbCellera Biologics Inc trades at $9.1 (market cap $2.99B), while Enbridge Inc trades at $51.74 (market cap $112.62B). The key difference: Enbridge Inc is far larger — about 37.7× AbCellera Biologics Inc's market cap, and Enbridge Inc pays a 5.34% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.

ABCLENB
Market Cap
$2.99B$112.62B
Sector
HealthEnergy
52-Week High
$9.76$58.04
52-Week Low
$2.78$45.23
Enterprise Value
$2.58B$196.53B
Dividend Yield
5.34%

Returns comparison

Trailing returns across standard periods

About AbCellera Biologics Inc

AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.

Read more on ABCL

About Enbridge Inc

Enbridge owns extensive midstream assets that transport hydrocarbons across the U.S. and Canada. Its pipeline network consists of the Canadian Mainline system, regional oil sands pipelines, and natural gas pipelines. The company also owns and operates a regulated natural gas utility and Canada's largest natural gas distribution company. Finally, the firm has a small renewables portfolio primarily focused on onshore and offshore wind projects.

Read more on ENB